Premium
Ing4 induces Cell Growth Inhibition in Human Lung Adenocarcinoma A549 Cells by Means of Wnt‐1/β‐Catenin Signaling Pathway
Author(s) -
Li Xiaomei,
Cai Limin,
Liang Meihua,
Wang Yandong,
Yang Jing,
Zhao Yulan
Publication year - 2008
Publication title -
the anatomical record: advances in integrative anatomy and evolutionary biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.678
H-Index - 62
eISSN - 1932-8494
pISSN - 1932-8486
DOI - 10.1002/ar.20685
Subject(s) - wnt signaling pathway , a549 cell , cell growth , adenocarcinoma , cancer research , biology , microbiology and biotechnology , signal transduction , apoptosis , cell cycle , growth inhibition , cancer , biochemistry , genetics
ING4, as a novel candidate tumor suppressor gene, has been implicated in several human malignances by tumor growth inhibition and apoptosis enhancement. The mechanism of ING4 remains largely unknown. The purpose of this study was to investigate the inhibitory tumor growth effects of ING4 on lung adenocarcinoma, and its mechanism, by ING4 cDNA transduction into A549 cells. Furthermore, the expression level of ING4 in lung adenocarcinoma tissues was examined. The expression of ING4 was markedly reduced in human lung adenocarcinoma tissues. Overexpression of ING4 can induce growth inhibition in A549 cells both in vitro and in vivo, and also induce up‐regulation of p27, down‐regulation of cyclinD1, SKP2, and Cox2, and inactivation of the Wnt‐1/β‐catenin pathway. Moreover, overexpression of ING4 can enhance the sensitivity of A549 cells to radiotherapy and chemotherapy. Thus, ING4 may play an inhibitory role on A549 cell proliferation and tumor growth in lung adenocarcinoma by up‐regulation or down‐regulation of cell proliferation‐regulating proteins such as p27, cyclinD1, SKP2, and Cox2 by means of inactivation of Wnt‐1/β‐catenin signaling. Anat Rec, 291:593–600, 2008. © 2008 Wiley‐Liss, Inc.